Utility of S100A12 as an Early Biomarker in Patients With ST-Segment Elevation Myocardial Infarction
Conclusions and Relevance: S100A12 rapidly identified patients with STEMI, more accurately than other cardiac biomarkers, especially within the first 2 h after symptom onset. The peak plasma S100A12 level was a strong predictor of 1-year prognosis after STEMI.PMID:34977174 | PMC:PMC8718434 | DOI:10.3389/fcvm.2021.747511
Source: Atherosclerosis - Category: Cardiology Authors: Xiaolin Zhang Minghui Cheng Naijing Gao Yi Li Chenghui Yan Xiaoxiang Tian Dan Liu Miaohan Qiu Xiaozeng Wang Bo Luan Jie Deng Shouli Wang Hongyan Tian Geng Wang Xinliang Ma Gregg W Stone Yaling Han Source Type: research
More News: Calcium | Cardiology | Emergency Medicine | Heart | Heart Attack | Heart Failure | Pain | Stroke